A molecular signature for anastasis, recovery from the brink of apoptotic cell death

During apoptosis, executioner caspase activity has been considered a point of no return. However, recent studies show that cells can survive caspase activation following transient apoptotic stimuli, a process called anastasis. To identify a molecular signature, we performed whole-transcriptome RNA s...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 216; no. 10; pp. 3355 - 3368
Main Authors Sun, Gongping, Guzman, Elmer, Balasanyan, Varuzhan, Conner, Christopher M, Wong, Kirsten, Zhou, Hongjun Robin, Kosik, Kenneth S, Montell, Denise J
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 02.10.2017
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:During apoptosis, executioner caspase activity has been considered a point of no return. However, recent studies show that cells can survive caspase activation following transient apoptotic stimuli, a process called anastasis. To identify a molecular signature, we performed whole-transcriptome RNA sequencing of untreated, apoptotic, and recovering HeLa cells. We found that anastasis is an active, two-stage program. During the early stage, cells transition from growth-arrested to growing. In the late stage, HeLa cells change from proliferating to migratory. Recovering cells also exhibited prolonged elevation of proangiogenic factors. Strikingly, some early-recovery mRNAs, including Snail, were elevated first during apoptosis, implying that dying cells poise to recover, even while under apoptotic stress. Snail was also required for recovery. This study reveals similarities in the anastasis genes, pathways, and cell behaviors to those activated in wound healing and identifies a repertoire of potential targets for therapeutic manipulation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.201706134